Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

INBX

Inhibrx Biosciences Inc.

Jun 14 • 04:00PM ET

15.70

Dollar change -0.89
Percentage change -5.36	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF XBI VTWO IWM VHT IWO VTWG LABU IWN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	38.35%	Shs Outstand	47.37M	Perf Week	-5.71%
Market Cap	227.34M	Forward P/E	-	EPS next Y	-	Insider Trans	-4.18%	Shs Float	8.92M	Perf Month	-49.13%
Income	-	PEG	-	EPS next Q	-	Inst Own	30.64%	Short Float	14.57%	Perf Quarter	-50.05%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	2.32	Perf Half Y	-35.34%
Book/sh	0.23	P/B	66.82	EPS next Y	-	ROA	-	Short Interest	1.30M	Perf Year	-34.98%
Cash/sh	17.44	P/C	0.90	EPS next 5Y	-	ROE	-	52W Range	12.85 - 35.73	Perf YTD	-53.99%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-56.06%	Beta	2.65
Dividend TTM	-	Quick Ratio	3.82	Sales past 5Y	-17.88%	Gross Margin	-	52W Low	22.22%	ATR (14)	1.30
Dividend Ex-Date	-	Current Ratio	3.82	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	23.24	Volatility	3.95% 4.93%
Employees	-	Debt/Eq	18.23	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	Yes / Yes	LT Debt/Eq	17.73	EPS Q/Q	-	Payout	-	Rel Volume	0.35	Prev Close	16.59
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	559.49K	Price	15.70
SMA20	-29.36%	SMA50	-42.79%	SMA200	-38.42%	Trades		Volume	193,964	Change	-5.36%

Inhibrx Biosciences, Inc. operates as an American clinical-stage biotechnology company for biologic therapeutic candidates. The private company is based in DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kayyem Jon Faiz	Director	Jun 05 '24	Buy	17.32	57,549	997,024	1,150,410	Jun 07 06:05 PM
Eckelman Brendan P.	Chief Scientific Officer	May 28 '24	Sale	34.30	300,000	10,290,000	1,735,553	May 30 06:21 PM
VIKING GLOBAL INVESTORS LP	10% Owner	Aug 28 '23	Buy	19.35	511,627	9,899,982	511,627	Aug 30 08:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INBX

Inhibrx Biosciences Inc.

Upgrade your FINVIZ experience